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What is already known about this subject? 
• Baseline depression is associated with greater attrition rates from weight management 
programmes and is also with poorer weight loss success. 
• There is little evidence regarding the role of baseline anxiety as a predictor of attrition or weight 
loss in weight management programmes. 
• There is some evidence that patients with baseline mood disorders achieve similar weight loss to 
controls in weight management programmes with an integrated psychological component 
 
What this study adds 
• This study confirms that baseline anxiety and depression (identified using HADS) is associated 
with higher attrition of patients from a weight management programme with an integrated 
psychology service. 
• Despite a significantly less favourable case-mix of risk-factors for poor weight loss: 
o Patients with severe anxiety at baseline achieve similar weight loss outcomes to those 
without baseline anxiety. 
o Significantly greater weight loss is seen in participants with severe baseline depression at 
all stages of follow-up in the Glasgow and Clyde Weight Management Service. 
 
  
Abstract 
Objective: To investigate the effect of baseline anxiety and depression, using different definitions for 
caseness, on attrition and weight outcomes following a multidisciplinary weight management 
programme. 
Design: Prospective observational study. The Hospital Anxiety and Depression Scale (HADS) was 
used to measure anxiety and depression with ‘caseness’ scoring ≥11 and severity ≥14. 
Participants: All patients who began a weight management programme between 1 October 2008 and 
30 September 2009 (n=1838). 
Setting: Glasgow and Clyde Weight Management Service (GCWMS) is a specialist multidisciplinary 
service, which aims to achieve a minimum of ≥5kg weight loss. Patients with HADS score ≥14 were 
referred to the integrated psychology service for psychological assessment/intervention. 
Results: Patients with caseness (HADS ≥11) for anxiety (33%) and depression (27%) were 
significantly younger, heavier, more socioeconomically deprived and a higher proportion were female. 
There was a significant positive correlation between HADS anxiety and depression scores and 
increasing BMI (r2=0.094, p<0.001 and r2=0.175, p<0.001, respectively). Attendance and completion 
was lower throughout follow-up amongst patients with anxiety or depression. More patients with 
HADS score ≥11 achieved ≥5kg or ≥5% weight loss and by 12 months those with anxiety had a 
significantly higher mean weight loss (p=0.032). Participants who scored for severe anxiety (HADS 
≥14) achieved similar weight loss to those without, whilst participants who scored for severe 
depression achieved significantly greater weight loss than non-cases at 3, 6 and 12 months of follow-
up (p<0.01). 
Conclusions: Despite a less favourable case-mix of risk-factors for poor weight loss, patients who 
scored caseness for severe anxiety/depression and were offered additional psychological input 
achieved similar or better weight loss outcomes. 
 
 
 
  
Introduction 
Obesity (Body Mass Index (BMI) ≥30kg/m2) and psychological distress, including anxiety and 
depression, frequently co-exist, particularly in women1–7. Anxiety disorders are characterized by 
feelings of anxiety and fear, where anxiety is a worry about future events and fear is a reaction to 
current events, whilst depressive disorders are a common form of mood disorder, characterized by 
sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, 
feelings of tiredness, and poor concentration8. The prevalence of anxiety and depression amongst 
obese individuals is greater than in the non-obese, and it appears that the prevalence increases with 
increasing BMI 1,9. Petry et al.10 identified a higher lifetime and past year prevalence of anxiety with 
obesity compared to normal BMI (20.7% vs. 16%, and 13.4% vs. 10.2% respectively), and these 
findings were confirmed in depression and obesity compared to normal BMI (20.4% vs. 16.4%, and 
8.5% vs. 7.15%). According to the World Health Organisation, the prevalence and burden of anxiety 
and depression are expected to rise to become the largest contributor to the global burden of disease 
by 2030 11,12. It is unclear the extent to which the obesity epidemic and the burden of mental health 
disorders will drive one another; however what is clear is the parallel between them. 
Attrition from weight management programmes is common and reduces the exposure to the 
intervention, which has been shown to result in poorer weight loss outcomes 13,14. Baseline 
depression 13–16 or a past history of depression17,18 have been shown to increase attrition from weight 
management programmes, most likely because the lethargy and lack of motivation often associated 
with depression prevents effective engagement with the demanding weight loss programmes 19. 
Literature is sparse regarding the role of anxiety disorders in weight loss programme dropout. 
Baseline depression has been shown to reduce weight loss success in weight management 
programmes 15,20,21 and predict weight gain 22; however baseline anxiety has only been identified as a 
negative predictor of weight loss success in bariatric patients 23,24.  
The UK National Institute for Clinical Excellence 25 has issued guidance on lifestyle weight 
management services identifying that they should be developed by a multidisciplinary team, including 
dieticians, psychologists and physical activity instructors. This advice takes into account the 
importance of behavioural change and psychologist input in weight management programmes, which 
have been shown to improve weight loss and maintenance26–28 rather than diet and exercise alone in 
the populations attending weight management services. There is some evidence that patients with 
baseline anxiety and/or depression achieve similar weight loss to controls in weight management 
programmes with an integrated psychological component 13,29–32. However, despite guidelines 
recommending psychologist input in weight management services, there is a lack of evidence for what 
screening tools should be used, what interventions should be provided and what their effectiveness is.  
This study examines the prevalence and associations of anxiety and/or depressive symptomatology 
at baseline in patients attending a multidisciplinary weight management programme with a Cognitive 
Behavioural Therapy (CBT) programme for all patients, with psychological screening and additional 
psychological intervention when required. Using different HADS scores to diagnose caseness (≥11) 
and define severity (≥14) for anxiety and depression, this study investigates the attrition and weight 
outcomes at 3, 6, and 12 months following dietary, exercise and psychological intervention. 
Methods 
Setting 
Glasgow and Clyde Weight Management Service 
NHS Greater Glasgow and Clyde (NHSGGC), population 1.2 million, implemented the Glasgow and 
Clyde Weight Management Service (GCWMS) model in 2008: a multicomponent weight management 
programme that is integrated across primary and secondary care, delivered in out-patient hospital 
settings and community-based sites. GCWMS aims to support individuals to achieve a minimum of ≥5 
kg weight loss. In the hierarchy of interventions for the treatment of obesity in NHSGGC, this service 
sits above local authority, commercial and third-sector services, on the pathway to bariatric surgery. 
Glasgow and Clyde Weight Management Service (GCWMS) is described in detail in previous 
publications 2,33 and is summarised here. GCWMS is a multidisciplinary weight management 
programme involving dietitians, clinical psychologists, physiotherapists and administrative staff. 
Patients aged 18 years and over with complex obesity (defined as BMI of ≥30 kg/m2 with obesity-
related comorbidities or BMI of ≥35 kg/m2) are eligible and referred by their GP or hospital doctor. 
Treatment pathways and goals were developed based on best evidence and national 
guidelines 27,2827,28.  
 
Integrated Psychology Service 
GCWMS have an integrated psychology service within their service model. All clients who access 
GCWMS have some level of psychological provision ranging from the least intensive: cognitive-
behavioural components incorporated within the standard weight management programme; to the 
most intensive: individual psychological assessment and therapy.  
 
A ‘matched-care’ model triages psychology assessments and interventions as efficiently as possible 
(see Figure 1). Clients are offered access to psychological approaches through psychological 
assessments; triage clinics (brief assessment) and psycho-educational talks. The more intense group-
interventions and individual therapy are directed to those with the more complex presentations. The 
current model of psychological provision requires qualified clinical psychologists to provide 
assessment/intervention and to support less intensive levels of treatment. 
 
Hospital Anxiety and Depression Scale (HADS) 
After referral to the service, all patients complete the Hospital Anxiety and Depression Scale 
questionnaire 34–36 at initial assessment. This measure is used to assess for symptoms of anxiety and 
depression to identify those that may require further psychological assessment/support. The scale 
assesses for presence of morbidity and gives an indication of severity, with a score of 11-14 indicating 
‘moderate disorder’ and ≥14 being a ‘severe disorder’37. A score of ≥11 for either anxiety or 
depression is used to indicate ‘caseness’, a threshold for diagnosis, and a score of ≥14 identifies 
those with more severe symptoms.  
 In GCWMS, all patients scoring ≥14 for anxiety and/or depression on the HADS are offered the option 
to opt-in for an additional psychology assessment and potential intervention with a clinical 
psychologist, in line with the matched care model detailed above and in Figure 1. Given the demands 
on the service and the capacity to provide the range of psychological interventions, this eligibility 
score was selected for the more severely symptomatic patients. Although it is higher than cut-offs 
used in other studies, within this routine service delivery it was selected as a way to match capacity 
with demand and to target the most psychologically distressed patients. Additionally, patients may 
also be referred to psychology relating to other difficulties such as disordered eating behaviours, low 
self-esteem, body image distress, interpersonal difficulties, past trauma, and cognitive impairments; 
however only their HADS score was considered in this study. Psychological assessment aims to 
identify the need for additional psychological intervention to support and manage their symptoms, to 
ultimately maximise their adherence with weight management interventions.  
Non-psychology GCWMS staff (dieticians and physiotherapists) are trained to interpret this screening 
measure at initial assessment. Clinical judgement is also encouraged regarding those who do not 
meet a score of ≥14 but may still benefit from additional psychological assessment/intervention; 
however these patients were not included in this study.  
Data and Analysis 
Definitions of completers and time points 
Patients were considered to be ‘completers’ if they attended ≥4/9 sessions in the lifestyle intervention 
phase, ≥2/3 sessions in the further weight loss treatment phase, and ≥6/12 sessions in the weight 
maintenance phase. This is consistent with a definition of completion used in another weight 
management programme in the UK with 50% attendance 38. Three, six or twelve month time points 
were described as follows: for three months, a weight recorded at 84 days (12 weeks) was used; if 
unavailable the range was extended from 70 to 98 days. For six months, a weight at 182 days (26 
weeks, extended range 154 to 210 days) and for 12 months, a weight measured at 364 days (52 
weeks, extended range 308 to 422 days).  
Socioeconomic status 
Patients’ socio-economic circumstances were estimated using the Scottish Index of Multiple 
Deprivation (SIMD) 39: an area-based index that uses seven domains (current income; employment; 
health; education, skills and training; geographic access to services; housing; and crime) to describe 
the level of deprivation in small geographic areas (data zones). All data zones in Scotland are ranked 
from 1 (most deprived) to 6505 (least deprived), and we used quintiles of the Scottish population, 
ranging from 1 (most deprived) to 5 (least deprived) to further categorise.  
Data and statistical methods 
All referrals to the GCWMS from 1 October 2008 to 30 September 2009 were followed until they 
completed or left the programme. Data were censored at 1 December 2011, so that full data were 
available on patients who completed the weight maintenance period, which occurred around 19 
months after starting the programme. Weight change from entry to the programme to 3, 6 and 12 
months is described. A conventional statistical significance cut-off of 5% was used. Primary analyses 
were carried out in all patients who began treatment. Missing data was due to patients failing to attend 
appointments or leaving the programme early; reasons for non-attendance are generally not known. 
Where data were missing, the method of last observation carried forward (LOCF) was preferred. 
Statistical tests for stratified analyses used chi-square tests for categorical variables and Kruskal-
Wallis for continuous variables. Independent t-tests and Pearson correlations were performed using 
the SPSS Statistical Software Package V.21. Non-identifiable data were provided by GCWMS for the 
purposes of evaluating a routine NHS service and consequently ethical committee review was not 
sought.  
  
 
Results 
Over the 1-year period from October 2008 to September 2009, 6505 referrals were made to GCWMS, 
of whom 5637 were eligible for the service, based on BMI, age, area of residence and comorbidities. 
Of the 5637 eligible patients, 61% (3460) opted into the service, 58% (3249) attended for 
assessment, 3 were deemed ineligible at assessment because their BMI was lower than 30 kg/m2, 
38% (2153) opted to enter phase 1 and 34% (1916) attended phase 1 at least once. From the dataset 
of 1916 patients, we excluded a further 4 whose initial BMI was recorded as ≤30 kg/m2 and 74 who 
were directed to a specialised disordered eating group (where they received different, specialised 
psychological interventions that are qualitatively different from the main programme), leaving a final 
sample for analysis of 1838 patients.  
 
Prevalence and baseline characteristics 
Anxiety and depression was prevalent amongst the 1838 patients who attended at least one session 
at the GCWMS, and using the widely used definition of HADS ≥11 to delineate caseness for moderate 
symptomatology, the prevalence of anxiety was 33% and 27% for depression. When using the 
GCWMS cut-off (≥14) for severity, 14.3% suffered from anxiety and 10.7% from depression, and this 
represents the proportion of patients who were offered additional psychological intervention.  There 
were 43 instances of missing HADS-Anxiety (HADS-A) score (2.3%) and 42 instances of missing 
HADS-Depression (HADS-D) score (2.3%). 
Table 1 describes the difference in baseline characteristics in those patients who commenced the 
GCWMS and shows comparative characteristics between HADS-A and HADS-D scores at cut-offs of 
11 and 14. There were significantly more women enrolled in the programme who scored ≥11 in 
HADS-A and -D, and patients were younger in the ≥11 group. The mean initial BMI was greater 
amongst those scoring ≥11 for HADS-A and HADS-D, and this is affirmed by the greater initial weight 
(kg). Additionally, patients who scored ≥11 for anxiety and depression were from more 
socioeconomically deprived backgrounds with almost half of patients being from the most deprived 
SIMD group.  
Those who scored ≥14 for HADS-A were significantly younger, more deprived and had a higher 
proportion of females than those who scored <14. There was a significant difference in baseline 
characteristics with a HADS-D score ≥14, where patients were significantly younger, heavier, and 
were also proportionately more female and deprived.  
Increasing HADS anxiety and depression scores are correlated with increasing BMI (HADS-A: 
r2=0.094, p<0.001; HADS-D: r2=0.175, p<0.001). However, despite the correlation, it is not possible to 
distinguish the directionality or causality of the relationship. 
Attendance and Completion 
The attendance and completion rates by HADS score are shown in Table 2. Both attendance and 
completion rates are lower amongst patients with anxiety and depression. Significantly fewer patients 
opted into the weight management programme when they scored for caseness (≥11) in HADS-A and 
HADS-D. Those who scored ≥11 for HADS-A had lower rates of completion at 6 months (p=0.001), 
and for HADS-D there were significantly fewer completers at 6 and 12 months (p=0.011 and p=0.024 
respectively). There were approximately 5% fewer completers who scored ≥14 in HADS-A compared 
to those who scored <14, and this difference was highly significant at 3, 6, and 12 months. For 
individuals who scored ≥14 in HADS-D, there were approximately 3% fewer completers at 3, 6, and 
12months, and differences were only significant at 12 months. 
Weight Outcomes 
Table 3a shows the 3, 6 and 12 month weight loss split by HADS-A and HADS-D </≥ 11 and </≥ 14 
respectively. At 3 and 6 months, those with HADS-A ≥11 had similar weight loss than those scoring 
<11, however by 12 months, those with HADS-A ≥11 had a higher mean weight loss. Table 3b shows 
a greater percentage of patients achieved ≥5% or ≥5kg weight loss with HADS-A ≥11 at 12 months 
compared to HADS-A <11. At 3 months, HADS-D ≥11 had significantly less weight loss, but there was 
no difference by 6 or 12 months. More patients with HADS-D ≥11 achieved ≥5kg weight loss at 3, 6, 
and 12 months compared to HADS-D <11.  
Patients who scored ≥14 for HADS-A had a similar weight loss to those who scored <14. However, 
those who scored ≥14 in HADS-D had a significantly greater weight loss at 3, 6, and 12 months of 
follow-up. There was no difference in the proportion of patients achieving ≥5% and/or ≥5kg weight 
loss between HADS-A severe cases and non-severe cases.  A higher percentage of those with 
HADS-D ≥14 achieved ≥5% and/or ≥5kg at 6, and 12 months compared to those who scored<14. 
 
Outcomes stratified by gender, age and socioeconomic status 
There was no difference in attrition at 12 months (Figure 2a-b) between males and females when 
stratified by HADS score. Men had greater weight loss compared to women in the absence of anxiety 
or depression (HADS <11 or <14). Men had highly significantly greater weight loss when they scored 
caseness for anxiety (HADS-A≥11) (male -4.61kg, female -3.48 kg, p=0.001). On examining each 
gender individually, there was no significant difference in attrition or weight change between patients 
with anxiety or depression (HADS ≥11 or ≥14) and those in whom it was absent (HADS <11 or <14). 
In patients without anxiety or depression, there was a trend for significantly less attrition at 12 months 
with increasing age, whilst in patients with caseness for anxiety (HADS-A ≥11) younger patients had 
higher attrition rates (approximately 90%) at 12 months compared to older patients (Supplementary 
Figure 1a-b). Weight loss at 12 months (Supplementary Figure 1c-d) was significantly less in 
younger patients compared to older patients without severe anxiety (HADS-A <14).. 
There was no evidence of any difference in attrition or weight loss at 12 months by HADS and 
socioeconomic deprivation (Supplementary Figures 2a-2d).  
  
Discussion  
This study shows that patients with complex obesity who score for caseness of severe anxiety and/or 
depression in a weight management service with integrated psychological input achieve the same or 
better weight loss outcomes than non-cases. Despite patients being at higher risk of poor weight 
outcomes due to patient mix of younger, more female and more deprived individuals, patients who 
were offered additional psychological input due to their psychological co-morbidity achieved equal or 
better outcomes than those without this additional input.  
HADS scores for caseness are usually defined at 11 in literature 34,37,40; however, GCWMS used 14 to 
indicate severity as the cut-off for psychological intervention due to resource constraints, and from this 
study population 1/3 of patients would have been eligible for the intervention if a cut-off of 11 had 
been used, which would be unsustainable. Consequently, HADS score of ≥14 selects approximately 
10-15% of patients, granted that these individuals are likely to have more significant and severe 
psychopathology.  
In patients who score for severe anxiety or depression symptoms, mean weight loss was significantly 
greater in patients with depression than those scoring <14; indicating a population who benefit most 
from the intervention, and importantly had a sustained benefit at 12 months. This is reinforced by 
more patients achieving ≥5kg and/or ≥5% weight loss at all stages of follow-up. Those scoring ≥14 in 
HADS-A achieve the same results as those who score ≤14 in HADS-A, which is consistent with other 
non-surgical weight management programmes 29. 
Our findings identify that those who have caseness for anxiety or depression (HADS ≥11) have similar 
weight outcomes to those who scored ≤11; however this study population includes those with HADS 
≥14 who had the option of additional psychological intervention and consequently may provide a 
falsely elevated estimate of weight loss in the caseness population. However, this distinction in 
classification emphasises the importance of providing intervention to the most severe cases, which 
enables them to achieve similar outcomes to those without anxiety or depression, or less severe 
forms.  
Factors affecting attendance, attrition and completion in weight management programmes have been 
widely studied, and are understood to be multifactorial 2,13,15,16,29, and it is well recognised that greater 
baseline psychological symptoms are positively associated with attrition. Despite being offered 
psychological intervention, patients with HADS-A or HADS-D scores ≥14 continued to have higher 
non-attendance and attrition than non-severe cases. Additional factors which can influence attrition 
include younger age, greater initial weight and deprivation2,15,29. In this study the patients with greater 
psychological co-morbidity were significantly younger, heavier and more deprived, ,however, in this 
population scoring ≥14 for HADS-A or HADS-D, with stratified analyses, there was no significant 
difference in attrition between gender, age or socioeconomic deprivation. 
Previous research by Morrison et al.2 identified baseline depression (HADS score ≥11) as a significant 
positive predictor of ≥5kg weight loss in both sexes (OR=1.81, 95% CI: 1.35,2.44) for the lifestyle 
intervention phase of this weight management service, and in women alone, anxiety was a significant 
positive predictor (OR=1.59, 95% CI: 1.16,2.18). These findings from an earlier stage of GCWMS are 
reinforced by this study. They additionally identified greater baseline weight (BMI ≥50 kg/m2), age ≥40 
years, and male sex as positive predictors of weight loss, whilst diabetes mellitus and socioeconomic 
deprivation were negative predictors. We found that men with symptoms of anxiety (HADS-A ≥11) had 
greater weight loss than women, but we did not identify any difference between age groups or 
socioeconomic deprivation in patients with caseness for anxiety and/or depression. 
Strengths and limitations 
The GCWMS is a very large NHS service which provides a real-life study cohort for follow-up and 
provides a broad population in which there is evidence of effective long-term weight loss. Importantly 
this is an undifferentiated population of all patients referred by community teams and a particular 
strength of our study is that we report on outcomes among all patients referred to the GCWMS rather 
than only on those who completed the programme. Our study benefits from a relatively large sample 
size, a diverse socio-economic catchment population, and objective measures of height and weight. 
The key issues with this study are the non-attendance and attrition which occurred throughout service 
follow-up, and the lack of available data to account for the reasons for this. There is no information 
about those who were never referred to the GCWMS and who constitute the “hidden” majority of 
eligible persons. We do not have data on attendance, attrition, the recommended intervention and 
completion of the targeted psychological component as these are not currently accessible in the 
electronic records. Additionally, there is a lack of ancillary information such as baseline 
characteristics, changes in clinical risk factors (e.g. blood pressure, lipids and glycaemic control) and 
post-intervention mental health symptoms.  
Further studies should review the effectiveness of specific psychological interventions, the cost-
effectiveness of this weight-management approach, investigate attendance and attrition, and also 
evaluate post-intervention mental health symptoms. 
 
Conclusions 
Patients with complex obesity who scored for severe anxiety and/or depression symptoms and were 
offered additional psychological input during their weight management programme achieved similar or 
better weight loss outcomes than non-severe cases, despite a less favourable case-mix of risk-factors 
for poor weight loss. Effort should focus on improving attendance at weight management services by 
patients with psychological difficulties such as anxiety and depression. 
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Table 1. Baseline characteristics of 1838 patients who commenced the GCWMS, stratified by HADS-A and HADS-D scores with severity cut-off 
scores of 11 and 14 
 
HADS-A HADS-D 
<11 ≥11 <14 ≥14 <11 ≥11 <14 ≥14 
N=1201 (67.0%) N=592 (33.0%) N=1538 (85.7%) N=257 (14.3%) N=1311 (73.1%) N=483 (26.9%) N=1603 (89.3%) N=193 (10.7%) 
Age 50.4 (13.7) 46.1 (12.4) ** 49.4 (13.6) 46.5 (11.9) ** 49.6 (14.0) 47.1 (11.7) ** 49.3 (13.7) 46.2 (11.2) ** 
% Male 29.6% 20.9% ** 27.5% 22.2% ** 29.0% 20.9% ** 27.3% 22.3%** 
Initial weight (kg) 117.3 (22.6) 119.9 (25.3) * 118.1 (23.4) 118.3 (24.7) 116.9 (22.9) 121.7 (25.0) 117.4 (22.8) 124.6 (28.6) ** 
Initial BMI (kg/m2) 42.8 (6.5) 44.3 (7.8) ** 43.2 (6.9) 43.7 (7.5) 42.7 (6.6) 44.9 (7.5) ** 43.0 (6.7) 45.5 (8.6) ** 
SIMD 2006 Quintile ** ** ** ** 
1 (most deprived) 487 (40.5%) 292 (49.3%) 646 (42.0%) 134 (52.1%) 541 (41.3%) 237 (49.1%) 679 (42.4%) 100 (51.8%) 
2 225 (18.7%) 107 (18.1%) 286 (18.6%) 46 (17.9%) 248 (18.9%) 85 (17.6%) 298 (18.6%) 35 (18.1%) 
3 161 (13.4%) 77 (13.0%) 209 (13.6%) 30 (11.7%) 180 (13.7%) 58 (12.0%) 213 (13.3%) 26 (13.5%) 
4 159 (13.2%) 61 (10.3%) 196 (12.7%) 24 (9.3%) 164 (12.5%) 56 (11.6%) 205 (12.8%) 15 (7.8%) 
5 (least deprived) 164 (13.7%) 54 (9.1%) 195 (12.7%) 23 (8.9%) 173 (13.2%) 46 (9.5%) 203 (12.7%) 16 (8.3%) 
 
HADS-A: Hospital Anxiety and Depression Scale for Anxiety; HADS-D: Hospital Anxiety and Depression Scale for Depression. 
 
Note: Comparisons between HADS scores by independent samples t-test (comparison of mean SIMD quintile category).*indicates p-value <0.05. ** indicates 
p-value <0.01.  
Table 2. Comparison of attendance and completion rates for HADS-A and HADS-D using severity score of ≥11 or ≥14.  
 
 
 
HADS-A HADS-D 
<11 ≥11 p-Value <14 ≥14 p-Value <11 ≥11 p-Value <14 ≥14 p-Value 
Opting into 
programme  
Total (N) 2022 1120  2612 530  2246 899  2741 404  
Opt in 1202 (59.4%) 
593 
(52.9%) 
<0.001 
1538 
(58.9%) 
257 
(48.5%) 
<0.001 
1312 
(58.4%) 
484 
(53.8%) 
<0.001 
1603 
(58.5%) 
193 
(47.8%) 
0.001 
Opt out 820 (40.6%) 
527 
(47.1%) 
1074 
(41.1%) 
273 
(51.5%) 
934 
(41.6%) 
415 
(46.2%) 
1138 
(41.5%) 
211 
(52.2%) 
Completion: 
3 months 
Completed 769 (64.0%) 
370 
(62.4%) 
0.200 
986 
(64.1%) 
152 
(59.1%) 
0.008 
841 
(64.1%) 
300 
(62.0%) 
0.112 
1024 
(63.9%) 
116 
(60.1%) 
0.068 
Did not 
complete 
433 
(36.0%) 
223 
(37.6%) 
552 
(35.9%) 
105 
(40.9%) 
471 
(35.9%) 
184 
(38.0%) 
579 
(36.1%) 77 (39.9%) 
Completion: 
6 months 
Completed 474 (39.4%) 
210 
(35.4%) 
0.001 
599 
(38.9%) 85 (33.1%) 
<0.001 
510 
(38.9%) 
173 
(35.7%) 
0.011 
614 
(38.3%) 69 (35.8%) 
0.136 
Did not 
complete 
728 
(60.6%) 
383 
(64.6%) 
939 
(61.1%) 
172 
(66.9%) 
802 
(61.1%) 
311 
(64.3%) 
989 
(61.7%) 
124 
(64.2%) 
Completion: 
12 months 
Completed 264 (22.0%) 
125 
(21.1%) 
0.390 
344 
(22.4%) 45 (17.5%) 
<0.001 
292 
(22.3%) 96 (19.8%) 
0.024 
352 
(22.0%) 36 (18.7%) 
0.028 
Did not 
complete 
938 
(78.0%) 
468 
(78.9%) 
1194 
(77.6%) 
212 
(82.5%) 
1020 
(77.7%) 
388 
(80.2%) 
1251 
(78.0%) 
157 
(81.3%) 
 
HADS-A: Hospital Anxiety and Depression Scale for Anxiety; HADS-D: Hospital Anxiety and Depression Scale for Depression. 
 
Note: Comparisons by independent samples t-test.
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Table 3a. Comparison of weight change at 3, 6 and 12 months in GCWMS using HADS score of 11 as diagnostic of anxiety and depressive illness 
and 14 as diagnostic of severe anxiety and depressive illness. Performed using LOCF analysis. 
  
 
HADS-A HADS-D 
N 
Mean weight change and 95% CI (kg) 
N 
Mean weight change and 95% CI (kg) 
3 Months 6 Months 12 Months 3 Months 6 Months 12 Months 
<11 1202 -2.69 (-2.89,-2.49) -3.42 (-3.69,-3.14) -3.52 (-3.84,-3.20) 1312 -2.70 (-2.89,-2.51) -3.44 (-3.70,-3.18) -3.64 (-3.96,-3.32) 
≥11 593 -2.67 (-2.98,-2.36) * -3.40 (-3.83,-2.97) -3.71 (-4.24,-3.19) * 484 -2.63 (-2.99,-2.27) * -3.32 (-3.81,-2.83) -3.43 (-3.98,-2.87) 
<14 1538 -2.73 (-2.91,-2.55) -3.48 (-3.72,-3.23) -3.65 (-3.95,-3.35) 1603 -2.66 (-2.83,-2.48) -3.37 (-3.60,-3.13) -3.54 (-3.82,-3.25) 
≥14 257 -2.42 (-2.85,-1.98) -3.01 (-3.61,-2.41) -3.20 (-3.91,-2.48) 193 -2.93 (-3.60,-2.26) ** -3.78 (-4.67,-2.90) ** -3.95 (-4.95,-2.95) ** 
 
HADS-A: Hospital Anxiety and Depression Scale for Anxiety; HADS-D: Hospital Anxiety and Depression Scale for Depression. 
 
Note: Comparisons (between HADS score groups) by independent samples t-test. *indicates p-value <0.05. ** indicates p-value <0.01 
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Table 3b. Comparison of weight outcomes at 3, 6 and 12 months in GCWMS using HADS score of 11 as diagnostic of anxiety and depressive 
illness and 14 as diagnostic of severe anxiety and depressive illness. Performed using LOCF analysis.  
 
  
HADS-A HADS-D 
N 3 Months 6 Months 12 Months N 3 Months 6 Months 12 Months 
Percentage lost ≥5% 
<11 1202 196 (16.3%) 275 (22.9%) 279 (23.2%) 1312 223 (17.0%) 305 (23.2%) 313 (23.9%) 
≥11 593 103 (17.4%) 144 (24.3%) 156 (26.3%) ** 484 76 (15.7%) 114 (23.6%) 122 (25.2%) 
<14 1538 257 (16.7%) 358 (23.3%) 373 (24.3%) 1603 269 (16.8%) 367 (22.9%) 380 (23.7%) 
≥14 257 42 (16.3%) 61 (23.7%) 62 (24.1%) 193 30 (15.5%) 52 (26.9%) * 55 (28.5%) ** 
Percentage lost ≥5kg 
<11 1202 251 (20.9%) 333 (27.7%) 322 (26.8%) 1312 276 (21.0%) 357 (27.2%) 354 (27.0%) 
≥11 593 140 (23.6%) * 172 (29.0%) 176 (29.7%) * 484 115 (23.8%) * 148 (30.6%) ** 144 (29.8%) * 
<14 1538 336 (21.8%) 434 (28.2%) 431 (28.0%) 1603 348 (21.7%) 442 (27.6%) 438 (27.3%) 
≥14 257 55 (21.4%) 71 (27.6%) 67 (26.1%) 193 43 (22.3%) 63 (32.6%) ** 60 (31.1%) * 
 
HADS-A: Hospital Anxiety and Depression Scale for Anxiety; HADS-D: Hospital Anxiety and Depression Scale for Depression. 
 
Note: Comparisons (between HADS score groups) by chi-square test with post-hoc analysis. *indicates p-value <0.05. ** indicates p-value <0.01. 
 
